title: Does smoking reduce the risk of neuroleptic parkinsonoids?
authors.affiliation: Psychiatric Hospital Wiesloch/Heidelberg, FRG.
authors.forename: B
authors.initials: B
authors.lastname: Wagner
authors.forename: G K
authors.initials: GK
authors.lastname: Wolf
authors.forename: G
authors.initials: G
authors.lastname: Ulmar
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D012307:Risk Factors; D012907:Smoking / Q000503:physiopathology*
chemical_list: D014150:Antipsychotic Agents